A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Recruiting · NCT06911827 · Registry updated 2026-04-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-04-07 | NCT06911827 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 113 |